We are live on ! Find out more
GGHC

Gilder Gagnon Howe & Co Portfolio holdings

AUM $8.34B
1-Year Est. Return 46.58%
This Fund
S&P 500
This Quarter Est. Return
+5.42%
1 Year Est. Return
+46.58%
3 Year Est. Return
+191.6%
5 Year Est. Return
+200.35%
10 Year Est. Return
+3,561.44%
AUM
$7.98B
AUM Growth
-$21.8M
Cap. Flow
-$149M
Cap. Flow %
-1.86%
Top 10 Hldgs %
34.31%
Holding
287
New
30
Increased
70
Reduced
150
Closed
36

Top Buys

Rank Stock Value
1
BSX icon
Boston Scientific
BSX
+$82.6M
2
EMBJ
Embraer S.A. ADS
EMBJ
+$56.2M
3
TBBB icon
BBB Foods
TBBB
+$39.9M
4
NTRA icon
Natera
NTRA
+$35.9M
5
LOAR icon
Loar Holdings
LOAR
+$29.9M

Sector Composition

Rank Sector Weight
1 Technology 31.65%
2 Consumer Discretionary 19.21%
3 Healthcare 16.85%
4 Communication Services 13.51%
5 Industrials 6.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IRTC icon
101
iRhythm Holdings
IRTC
$4B
$13.6M 0.17%
126,395
+80,401
+175% +$8.21M
ENPH icon
102
Enphase Energy
ENPH
$5.17B
$13.3M 0.17%
133,023
+282
+0.2% +$32.8K
BIIB icon
103
Biogen
BIIB
$30B
$13.2M 0.17%
57,031
-2,910
-5% -$632K
WRB icon
104
W.R. Berkley
WRB
$26.7B
$13.2M 0.17%
251,577
-320
-0.1% -$17.1K
BECN
105
DELISTED
Beacon Roofing Supply, Inc.
BECN
$13.2M 0.16%
145,418
-411
-0.3% -$39.6K
TEAM icon
106
Atlassian
TEAM
$26.2B
$13.1M 0.16%
73,862
-4,048
-5% -$723K
QTRX icon
107
Quanterix
QTRX
$171M
$12.3M 0.15%
932,799
-241,119
-21% -$4.03M
BV icon
108
BrightView Holdings
BV
$1.24B
$12.1M 0.15%
+912,908
New +$11.6M
CSGP icon
109
CoStar Group
CSGP
$11.9B
$12.1M 0.15%
163,520
+21,156
+15% +$1.79M
AAPL icon
110
Apple
AAPL
$4.49T
$11.8M 0.15%
55,815
-18,156
-25% -$3.39M
OKTA icon
111
Okta
OKTA
$24.9B
$11.5M 0.14%
122,495
-3,611
-3% -$342K
MDGL icon
112
Madrigal Pharmaceuticals
MDGL
$11B
$10.8M 0.13%
38,377
-706
-2% -$168K
CP icon
113
Canadian Pacific Kansas City
CP
$78.4B
$10.5M 0.13%
132,841
-27,844
-17% -$2.27M
SU icon
114
Suncor Energy
SU
$78.4B
$9.81M 0.12%
257,491
-7,420
-3% -$287K
SITM icon
115
SiTime
SITM
$16.6B
$9.57M 0.12%
76,950
+20
+0% +$2.13K
MMYT icon
116
MakeMyTrip
MMYT
$5.8B
$9.45M 0.12%
112,310
-360
-0.3% -$26.9K
KRNT icon
117
Kornit Digital
KRNT
$723M
$9.09M 0.11%
620,776
+15,203
+3% +$235K
ENVX icon
118
Enovix
ENVX
$921M
$8.9M 0.11%
658,005
-50,614
-7% -$423K
GE icon
119
GE Aerospace
GE
$380B
$8.84M 0.11%
55,584
-13,716
-20% -$2.19M
MUSA icon
120
Murphy USA
MUSA
$11B
$8.61M 0.11%
18,330
-453
-2% -$197K
ARVN icon
121
Arvinas
ARVN
$516M
$7.59M 0.1%
285,099
-39,745
-12% -$1.27M
CARG icon
122
CarGurus
CARG
$3.33B
$7.49M 0.09%
+285,913
New +$6.8M
CPNG icon
123
Coupang
CPNG
$29.8B
$7.46M 0.09%
+356,031
New +$7.72M
TSM icon
124
TSMC
TSM
$2.1T
$7.45M 0.09%
+42,879
New +$6.5M
MAG
125
DELISTED
MAG Silver
MAG
$7.36M 0.09%
630,984
-15,271
-2% -$192K

Similar funds

Gilder Gagnon Howe & Co's Q2 2024 Portfolio in Review

As of Q2 2024, Gilder Gagnon Howe & Co held 287 positions worth $7.98B, down 0.27% from $8B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Gilder Gagnon Howe & Co's Q2 2024 filing shows 30 new, 70 increased, 150 reduced and 36 closed positions. Its largest new stake was Boston Scientific: 1,128,740 shares worth $86.9M. The largest sale was Shockwave Medical, Inc. Common Stock, an estimated $171M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 34% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Gilder Gagnon Howe & Co's largest Q2 2024 buy was Boston Scientific: 1,128,740 shares worth $86.9M.
  • Gilder Gagnon Howe & Co added most to BBB Foods in Q2 2024, an estimated $39.9M increase.
  • Gilder Gagnon Howe & Co's biggest Q2 2024 reduction was NVIDIA, cutting an estimated $107M.
  • Gilder Gagnon Howe & Co fully exited Shockwave Medical, Inc. Common Stock in Q2 2024, selling an estimated $171M.
  • Gilder Gagnon Howe & Co's ten largest holdings make up 34% of its $7.98B portfolio in Q2 2024.
  • Gilder Gagnon Howe & Co opened 30 new positions and closed 36 in Q2 2024.
  • Gilder Gagnon Howe & Co's portfolio value fell 0.27% quarter-over-quarter to $7.98B.

Based on Gilder Gagnon Howe & Co's 13F filing for Q2 2024, filed 14 Aug 2024.